246 related articles for article (PubMed ID: 34152963)
1. Effects of COVID-19 Vaccination Timing and Risk Prioritization on Mortality Rates, United States.
Wang X; Du Z; Johnson KE; Pasco RF; Fox SJ; Lachmann M; McLellan JS; Meyers LA
Emerg Infect Dis; 2021 Jul; 27(7):1976-1979. PubMed ID: 34152963
[TBL] [Abstract][Full Text] [Related]
2. Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa.
Williams V; Edem B; Calnan M; Otwombe K; Okeahalam C
Emerg Infect Dis; 2021 Aug; 27(8):2009-2016. PubMed ID: 34138694
[TBL] [Abstract][Full Text] [Related]
3. Disparities in First Dose COVID-19 Vaccination Coverage among Children 5-11 Years of Age, United States.
Murthy NC; Zell E; Fast HE; Murthy BP; Meng L; Saelee R; Vogt T; Chatham-Stephens K; Ottis C; Shaw L; Gibbs-Scharf L; Harris L; Chorba T
Emerg Infect Dis; 2022 May; 28(5):986-989. PubMed ID: 35226801
[TBL] [Abstract][Full Text] [Related]
4. Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination.
Salzman MB; Huang CW; O'Brien CM; Castillo RD
Emerg Infect Dis; 2021 Jul; 27(7):1944-1948. PubMed ID: 34034858
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Vaccination Coverage, Intent, Knowledge, Attitudes, and Beliefs among Essential Workers, United States.
Nguyen KH; Yankey D; Coy KC; Brookmeyer KA; Abad N; Guerin R; Syamlal G; Lu PJ; Baack BN; Razzaghi H; Okun A; Singleton JA
Emerg Infect Dis; 2021 Nov; 27(11):2908-2913. PubMed ID: 34586060
[TBL] [Abstract][Full Text] [Related]
6. Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel.
Hughes K; Gogineni V; Lewis C; Deshpande A
Curr Med Res Opin; 2021 Jun; 37(6):907-909. PubMed ID: 33760673
[TBL] [Abstract][Full Text] [Related]
7. The impacts of COVID-19 vaccine timing, number of doses, and risk prioritization on mortality in the US.
Wang X; Du Z; Johnson KE; Pasco RF; Fox SJ; Lachmann M; McLellan JS; Meyers LA
medRxiv; 2021 Feb; ():. PubMed ID: 33501453
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United States.
Sherman AC; Babiker A; Sieben AJ; Pyden A; Steinberg J; Kraft CS; Koelle K; Kanjilal S
Clin Infect Dis; 2021 Mar; 72(5):e154-e157. PubMed ID: 33161424
[TBL] [Abstract][Full Text] [Related]
9. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
Plotkin SA
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.
Swift MD; Breeher LE; Tande AJ; Tommaso CP; Hainy CM; Chu H; Murad MH; Berbari EF; Virk A
Clin Infect Dis; 2021 Sep; 73(6):e1376-e1379. PubMed ID: 33900384
[TBL] [Abstract][Full Text] [Related]
11. Spotlight on Vaccines: Pandemic May Open Gateway to Improve Vaccination Rates in Texas.
Price S
Tex Med; 2021 Mar; 117(3):20-25. PubMed ID: 34855954
[TBL] [Abstract][Full Text] [Related]
12. Severe Multisystem Inflammatory Symptoms in 2 Adults after Short Interval between COVID-19 and Subsequent Vaccination.
Jenny-Avital ER; Howe RA
Emerg Infect Dis; 2022 May; 28(5):1017-1020. PubMed ID: 35320702
[TBL] [Abstract][Full Text] [Related]
13. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
14. Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study.
Foy BH; Wahl B; Mehta K; Shet A; Menon GI; Britto C
Int J Infect Dis; 2021 Feb; 103():431-438. PubMed ID: 33388436
[TBL] [Abstract][Full Text] [Related]
15. [Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].
Dabanch J; Bastías M; Endeiza ML; Díaz E; Inostroza J; Cerda J; Santillana S; Rodríguez J; González C; Rodríguez M; Pizarro A
Rev Chilena Infectol; 2021 Apr; 38(2):185-188. PubMed ID: 34184708
[TBL] [Abstract][Full Text] [Related]
16. How severe would prioritization-induced bottlenecks need to be offset the benefits from prioritizing COVID-19 vaccination to those most at risk in New York City?
Kim HY; Bershteyn A; McGillen JB; Braithwaite RS
BMC Public Health; 2023 Jan; 23(1):174. PubMed ID: 36698103
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know.
Rasmussen SA; Kelley CF; Horton JP; Jamieson DJ
Obstet Gynecol; 2021 Mar; 137(3):408-414. PubMed ID: 33370015
[TBL] [Abstract][Full Text] [Related]
19. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
20. Principles and new perspectives in the vaccination against SARS-CoV-2 virus.
Smetanová J; Střížová Z; Bartůňková J; Milota T
Cas Lek Cesk; 2020; 159(7-8):298-302. PubMed ID: 33445936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
